The risk of secondary tumors in patients who have received mediastinal radiation therapy is well-known. Microglandular adenosis of the breast is a rare lesion that is considered benign, although its possible role as a precursor of invasive breast carcinoma has been considered. We present a case of microglandular adenosis in a patient who received mediastinal radiation therapy in childhood for Hodgkin's lymphoma. To our knowledge, this is the first reported case of microglandular adenosis in a patient with mediastinal radiotherapy which may shed light on its pathogenesis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.patol.2020.01.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
New insights into acinic cell carcinoma of the breast: clinicopathology, origin of histology, molecular features, prognosis, and treatment.
Front Oncol
September 2024
Department of Pathology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Article Synopsis
- * Diagnosis relies on the presence of specific granular cytoplasm and markers indicating serous acinar differentiation, and despite being seen as a low-grade form of triple-negative breast cancer (TNBC), over a quarter of patients face poor outcomes.
- * The text reviews current literature on AciCC, proposing it may develop from microglandular adenosis (MGA), and aims to clarify its origins, molecular traits, and treatment options, as this has not been thoroughly summarized before.
Diagnostic Accuracy of Mammographic Findings in Patients 35 Years and Older Presenting with Palpable Breast Lump in University of Benin Teaching Hospital, Benin City.
West Afr J Med
May 2024
Department of Surgery, University of Benin Teaching Hospital, Benin City, Nigeria. Phone number- +2348037214386; E-mail-
Background: Mammography has become an invaluable tool for diagnosing breast lesions and detecting early breast cancer in women of 35 years and above.
Aims: To correlate the mammography Breast Imaging Reporting and Data System (BI-RADS) categories with the histology in breast lesions and to determine the predictive values, sensitivity, specificity and accuracy of mammography.
Patients And Method: This was a one- year prospective study carried out from March 2015 to February 2016.
Meta-analysis of contrast-enhanced ultrasound in differential diagnosis of breast adenosis and breast cancer.
J Clin Ultrasound
November 2024
Department of Electrodiagnosis, Jilin Province FAW General Hospital, Changchun, China.
This systematic review and meta-analysis study aimed to determine the total capacity of contrast-enhanced ultrasound (CEUS) in the differential diagnosis of breast lesions and breast cancer. For collecting papers, four groups of keywords were searched in five databases. The required information was extracted from the selected papers.
View Article and Find Full Text PDFDanazol's use for menstrual suppression in transgender individuals: A retrospective multi-site cohort study.
Womens Health (Lond)
July 2024
Division of Gynecology, Department of Surgery, Boston Children's Hospital, Boston, MA, USA.
Article Synopsis
- - Danazol is a synthetic progestin with androgenic effects approved for treating conditions like endometriosis and is increasingly used for menstrual suppression in transgender and nonbinary individuals, despite a lack of research on its efficacy in this population
- - A retrospective study reviewed the experiences of transgender patients using danazol for menstrual suppression at two healthcare centers between 2000 and 2022, comparing those who did and did not use the treatment
- - Results indicated that most patients remained on danazol during follow-ups, with improvements in gender dysphoria, pelvic pain, and menstrual symptoms, and most achieved amenorrhea, suggesting its potential as an effective option for menstrual suppression in this demographic
Prognostic significance of alpha-2-macrglobulin and low-density lipoprotein receptor-related protein-1 in various cancers.
Am J Cancer Res
June 2024
Department of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University Chalubinskiego 6A, 50-368 Wroclaw, Poland.
Cancer is the leading cause of death worldwide. The World Health Organization (WHO) estimates that 10 million fatalities occurred in 2023. Breast cancer (BC) ranked first among malignancies with 2.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!